An extract of Synedrella nodiflora (L) Gaertn exhibits antidepressant properties through monoaminergic mechanisms

Metabolic Brain Disease
Patrick AmoatengThomas K Karikari

Abstract

Synedrella nodiflora (SNE) has been used traditionally for many neurological conditions and some of these neuroactive effects have been scientifically substantiated. The usefulness of SNE in depression has however not been investigated despite the availability of data in other disease models indicating it may be useful. The present study therefore examined the effect of SNE in acute murine models of depression and the possible mechanisms mediating its activities in these models. Preliminary qualitative phytochemical and high performance liquid chromatography (HPLC) screening were conducted on SNE. The behavioural effects of SNE (100, 300 and 1000 mg/kg) pre-treated mice were examined in the forced swimming (FST) and tail suspension (TST) tests. Behavioural events such as mobility (swimming, climbing, curling and climbing), and immobility, were scored. The possible involvement of monoamines in the effects of SNE was assessed in the TST by pre-treating mice with α-methyldopa, reserpine and para-chlorophenylalanine (pCPA) in separate experiments. Flavonoids, tannins, saponins, alkaloids, cardiac glycosides, coumarins, triterpenes, sterols, anthraquinones and phenolic compounds were present in SNE. HPLC analysis revealed the presen...Continue Reading

References

Jan 1, 1994·The Journal of Neuropsychiatry and Clinical Neurosciences·H S Mayberg
Aug 14, 1999·Journal of Geriatric Psychiatry and Neurology·M S LantzV Giambanco
Jan 29, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C López-Rubalcava, I Lucki
Feb 22, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J P RénéricL Stinus
May 2, 2001·Nature Reviews. Neuroscience·M L Wong, J Licinio
Apr 5, 2002·Neuron·Eric J NestlerLisa M Monteggia
Nov 27, 2002·European Journal of Pharmacology·Ryan R MetzgerAnnette E Fleckenstein
Aug 6, 2003·Behavioural Brain Research·Nadège RipollMichel Bourin
May 26, 2004·Pharmacology, Biochemistry, and Behavior·Ewa PoleszakGabriel Nowak
Dec 21, 2004·Psychopharmacology·Benoit Petit-DemouliereMichel Bourin
May 7, 2005·Metabolism: Clinical and Experimental·Madhu Kalia
Sep 28, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Masato FukuiWilliam C Wetsel
Dec 9, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chandra C CardosoAna Lúcia S Rodrigues
Mar 5, 2009·Molecular Neurobiology·Thomas S Guillot, Gary W Miller
Jul 28, 2009·Progress in Neuro-psychopharmacology & Biological Psychiatry·Haixia DangYuqing Wang
Jan 6, 2012·The International Journal of Neuropsychopharmacology·Esther BerrocosoJuan Antonio Mico
Jun 12, 2012·Current Pharmaceutical Design·Tanja Maria MichelJohannes Thome
Jan 1, 2011·Journal of Complementary & Integrative Medicine·Sumi WijayaChristophe Wiart
Dec 12, 2012·Trends in Neurosciences·Pierre-Eric Lutz, Brigitte L Kieffer
Mar 22, 2013·Annual Review of Public Health·Ronald C Kessler, Evelyn J Bromet
Jul 22, 2014·ISRN Pharmacology·Kennedy K E KukuiaDonatus W Adongo
Feb 25, 2015·Journal of Pharmacy & Bioallied Sciences·Kennedy K E KukuiaEmmanuel Addae
Feb 27, 2015·Journal of Basic and Clinical Physiology and Pharmacology·Patrick AmoatengAlexander Kwadwo Nyarko
Aug 9, 2017·BMC Complementary and Alternative Medicine·Patrick AmoatengSamuel B Kombian

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapies

Software Mentioned

GraphPad
GraphPad Prism
JWatcher
Sigma Plot

Related Concepts

Related Feeds

Cardiac Glycosides

Cardiac glycosides are a diverse family of naturally derived compounds that bind to and inhibit na+/k+-atpase. Discover the latest research on cardiac glycosides heres.